loading page

Creutzfeldt-Jakob disease with neuroleptic malignant syndrome
  • +3
  • Julija Čiauškaitė,
  • Ieva Puleikytė,
  • Simonas Jesmanas,
  • Giedrė Jurkevičienė,
  • Antanas Vaitkus,
  • Daiva Rastenytė
Julija Čiauškaitė
Lithuanian University of Health Sciences
Author Profile
Ieva Puleikytė
Lithuanian University of Health Sciences
Author Profile
Simonas Jesmanas
Lithuanian University of Health Sciences
Author Profile
Giedrė Jurkevičienė
Lithuanian University of Health Sciences
Author Profile
Antanas Vaitkus
Lithuanian University of Health Sciences
Author Profile
Daiva Rastenytė
Lithuanian University of Health Sciences
Author Profile

Abstract

Creutzfeldt – Jakob disease (CJD) is a rare neurodegenerative disease with complex clinical manifestations. Neuroleptic malignant syndrome (NMS) is a complication of antipsychotic medications which are used to treat neuropsychiatric symptoms of CJD. We present a case of a 51-year-old woman with CJD who developed NMS after being prescribed quetiapine.

Peer review status:ACCEPTED

15 Jun 2021Submitted to Clinical Case Reports
18 Jun 2021Submission Checks Completed
18 Jun 2021Assigned to Editor
23 Jun 2021Reviewer(s) Assigned
12 Jul 2021Review(s) Completed, Editorial Evaluation Pending
13 Jul 2021Editorial Decision: Revise Minor
20 Jul 20211st Revision Received
20 Jul 2021Submission Checks Completed
20 Jul 2021Assigned to Editor
20 Jul 2021Review(s) Completed, Editorial Evaluation Pending
24 Jul 2021Reviewer(s) Assigned
27 Jul 2021Editorial Decision: Accept